ES2161758T3 - Producto de copulacion de la histamina y de un acido aminado. - Google Patents

Producto de copulacion de la histamina y de un acido aminado.

Info

Publication number
ES2161758T3
ES2161758T3 ES94907600T ES94907600T ES2161758T3 ES 2161758 T3 ES2161758 T3 ES 2161758T3 ES 94907600 T ES94907600 T ES 94907600T ES 94907600 T ES94907600 T ES 94907600T ES 2161758 T3 ES2161758 T3 ES 2161758T3
Authority
ES
Spain
Prior art keywords
histamine
radical
represent
replaced
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94907600T
Other languages
English (en)
Inventor
Marc Babizhayev
Marie-Christine Seguin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exsymol SAM
Original Assignee
Exsymol SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9302295A external-priority patent/FR2701947B1/fr
Application filed by Exsymol SAM filed Critical Exsymol SAM
Application granted granted Critical
Publication of ES2161758T3 publication Critical patent/ES2161758T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A UN PRODUCTO SEUDODIPEPTIDO OBTENIDO POR ACOPLAMIENTO ENTRE LA HISTAMINA O LA HISTAMINA METILSUSTITUIDA Y UN AMINOACIDO QUE TIENE POR FORMULA (I), EN LA QUE A REPRESENTA UN RADICAL ELEGIDO EN EL GRUPO QUE CONSISTE EN RADICALES AMINOS, AMIDOS, LACTAMOS URETANOS; R{1}, R''{1}, R2, R''{2}....R{N}, R''{N} REPRESENTAN CADA UNO UN ATOMO DE HIDROGENO, UN RADICAL HIDROCARBONADO O UN GRUPO FUNCIONAL; Y Y Z REPRESENTAN CADA UNO UN ATOMO DE HIDROGENO O DE FLUOR, O UN RADICAL HIDROCARBONADO QUE PUEDE ESTAR SUSTITUIDO POR UNO O VARIOS GRUPOS FUNCIONALES; Y N ES UN NUMERO ENTERO SUPERIOR O IGUAL A 1: SIENDO LA CONEXION COVALENTE CON LA HISTAMINA O LA HISTAMINA METIL-SUSTITUIDA UNA CONEXION PEPTIDICA ENTRE EL RADICAL CARBOXILICO DEL AMINOACIDO Y EL RADICAL AMINO DE LA HISTAMINA. LOS PRODUCTOS SEUDODIPEPTIDOS DE LA INVENCION PUEDEN SER UTILIZADOS EN VARIAS APLICACIONES TERAPEUTICAS, COSMETOLOGICAS Y AGROALIMENTARIAS Y EN PARTICULAR PARA EL TRATAMIENTO DE LA CATARATA.
ES94907600T 1993-02-22 1994-02-21 Producto de copulacion de la histamina y de un acido aminado. Expired - Lifetime ES2161758T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9302295A FR2701947B1 (fr) 1993-02-22 1993-02-22 Produit de couplage de l'histamine et d'un acide aminé, procédé de préparation, et applications thérapeutiques et cosmétologiques.
FR9310486A FR2701948B1 (fr) 1993-02-22 1993-08-30 Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.

Publications (1)

Publication Number Publication Date
ES2161758T3 true ES2161758T3 (es) 2001-12-16

Family

ID=26230131

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94907600T Expired - Lifetime ES2161758T3 (es) 1993-02-22 1994-02-21 Producto de copulacion de la histamina y de un acido aminado.

Country Status (11)

Country Link
US (1) US5792784A (es)
EP (1) EP0684944B1 (es)
JP (1) JP3373852B2 (es)
BR (1) BR9406126A (es)
DE (1) DE69427814T2 (es)
ES (1) ES2161758T3 (es)
FR (1) FR2701948B1 (es)
GR (1) GR3036979T3 (es)
MX (1) MX9401347A (es)
RU (1) RU2166510C2 (es)
WO (1) WO1994019325A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711990B1 (fr) * 1993-11-05 1995-12-08 Exsymol Sa Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
CA2187482A1 (en) * 1995-10-13 1997-04-14 Eri Inoue Pharmaceutical composition
JP3877807B2 (ja) * 1996-07-03 2007-02-07 ゼリア新薬工業株式会社 口内炎治療・予防剤
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
AU742237B2 (en) * 1998-07-14 2001-12-20 Alcon Manufacturing Limited Use of 11-(3-dimenthylaminopropylidene)-6,11-dihydrodibenz (B,E)oxepin-2-acetic acid for the manufacture of medicament for treating non-allergic opthalmic inflammatory disorders and for the prevention of ocular neovascularization
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
DE50214837D1 (de) * 2001-09-06 2011-02-10 Lonza Ag Verfahren zur herstellung von beta-alaninamiden
US20030149090A1 (en) * 2001-11-06 2003-08-07 Gehlsen Kurt R. Compositions for the treatment of infectious diseases
JP2003171276A (ja) * 2001-11-30 2003-06-17 Menicon Co Ltd 眼精疲労改善眼科用組成物
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
MC200060A1 (fr) * 2002-10-04 2003-05-28 M Exsymol Sa Produit de couplage entre la tryptamine et un alpha-aminoacide son procédé de préparation et son application dans le domaine de la neuro-cosmétique
JPWO2004064866A1 (ja) 2003-01-20 2006-05-18 イノヴェイティブ ヴィジョン プロダクツ インコーポレーテッド カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
AU2003226582A1 (en) * 2003-04-18 2004-11-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
FR2980377B1 (fr) * 2011-09-22 2013-10-04 Total Raffinage Marketing Procede de regeneration d'un catalyseur enzymatique
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP6326601B2 (ja) 2013-03-13 2018-05-23 アンティース ソシエテ アノニム 皮膚更新のためのペプチド及び前記ペプチドを使用する方法
FR3030523B1 (fr) * 2014-12-18 2017-01-20 Oreal Nouveaux composes de la famille des n-acylamino-amides,compositions les comprenant, et utilisations
CN110981810A (zh) * 2019-12-19 2020-04-10 东莞市维琪科技有限公司 一种脱羧肌肽的合成方法
CN114213336A (zh) * 2021-12-24 2022-03-22 深圳瑞德林生物技术有限公司 β-丙氨酰-L-组氨的制备方法
CN114250204B (zh) * 2021-12-29 2024-02-09 深圳瑞德林生物技术有限公司 一种羧酸还原酶突变体及酶法合成脱羧肌肽的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381239A (en) * 1981-02-10 1983-04-26 Tanabe Seiyaku Co., Ltd. Method for reducing the pyrogen content of or removing pyrogens from substances contaminated therewith
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
WO1989003842A1 (en) * 1987-10-21 1989-05-05 The Upjohn Company Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
EP0571390B1 (en) 1990-11-23 2000-03-08 Peptech Limited The delay, prevention and/or reversal of cell senescence
DE69231576T2 (de) * 1991-09-09 2001-06-13 Peptech Ltd Verwendung von Peptiden ZUR BEHANDLUNG VON KOMPLIKATIONEN UND PATHOLOGY BEI DIABETES

Also Published As

Publication number Publication date
EP0684944B1 (fr) 2001-07-25
WO1994019325A1 (fr) 1994-09-01
US5792784A (en) 1998-08-11
JP3373852B2 (ja) 2003-02-04
FR2701948A1 (fr) 1994-09-02
DE69427814T2 (de) 2002-04-04
MX9401347A (es) 1994-08-31
FR2701948B1 (fr) 1996-07-26
JPH08506825A (ja) 1996-07-23
RU2166510C2 (ru) 2001-05-10
DE69427814D1 (de) 2001-08-30
GR3036979T3 (en) 2002-01-31
BR9406126A (pt) 1996-02-13
EP0684944A1 (fr) 1995-12-06

Similar Documents

Publication Publication Date Title
ES2161758T3 (es) Producto de copulacion de la histamina y de un acido aminado.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2191052T3 (es) Vacuna polinucleotida contra el virus del papiloma.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
DK0790974T3 (da) Substituerede 4-biarylsmør- eller 5-biarylpentansyrer og derivater som matrixmetalloproteaseinhibitorer
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2066045T3 (es) Derivados de acido poliaspartico como medio de recubrimiento para medicamentos y alimentos.
FR2679906B1 (fr) Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
AR012723A1 (es) Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos
ES2066390T3 (es) Nuevos derivados del espiro-(4.5)-decano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK569088A (da) Joderede polymerer og fremgangsmaade til fremstilling deraf samt deres anvendelse som kontrastmidler
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
MX9206806A (es) Pudines listos para tomar que contienen polifosfato
ES2135023T3 (es) Utilizacion de un decapeptido con actividad de tipo benzodiazepina para la preparacion de medicamentos y complementos alimentarios.
AR002264A1 (es) 6-[triazolil[3(trifluormetil)fenil]metil]-2-quinolinonas y quinolintionas, un procedimiento para su preparacion, una composicion que las comprende, unprocedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento y un intermediario.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
DK102787D0 (da) Isohexidnucleosider og farmaceutiske praeparater indeholdende disse
ES2182909T3 (es) Nueva utilizacion y nuevos derivados del imidazol, su procedimiento de preparacion, nuevos productos intermedios obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
PT98190A (pt) Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao
ECSP034739A (es) Derivados sustituidos de la propano-1,3-diamina y sus usos farmaceuticos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 684944

Country of ref document: ES